Month: April 2020

Company AnnouncementNet sales of DARZALEX® in the first quarter of 2020 totaled USD 937 millionGenmab will receive royalties on worldwide sales from Janssen Biotech, Inc.Copenhagen, Denmark; April 14, 2020 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX (daratumumab) as reported by Johnson & Johnson were USD 937 million in the first quarter of 2020. Net trade sales were USD 463 million in the U.S. and USD 474 million in the rest of the world. Genmab will receive royalties on the worldwide net sales of DARZALEX under the exclusive worldwide license to Janssen Biotech, Inc. to develop, manufacture and commercialize DARZALEX.About DARZALEX®(daratumumab)DARZALEX® (daratumumab) intravenous infusion is indicated for the treatment of adult patients in the United States: in combination with bortezomib,...

Marel hf. will publish its Q1 2020 interim condensed consolidated financial statements after market closing on 20 April 2020.Earnings conference call and webcastOn Tuesday 21 April 2020, at 8:30 am GMT (10:30 am CET), Marel will host a virtual investor meeting where CEO Arni Oddur Thordarson and CFO Linda Jonsdottir will give an overview of the financial results and operational highlights in the first quarter.The meeting will be webcast live on www.marel.com/webcast and a recording will be available after the meeting on marel.com/ir.Members of the investment community can join the conference call at:IS: +354 800 7520NL: +31 20 721 9496UK: +44 33 3300 9268US: +1 833 823 0586Financial calendarQ2 2020 – 22 July 2020Q3 2020 – 20 October 2020Q4 2020 – 3 February 2021Investor relationsFor further information, please contact Marel Investor Relations...

Marel hf. mun birta uppgjör fyrsta ársfjórðungs 2020 eftir lokun markaðar þann 20. apríl 2020.Rafrænn afkomufundur með markaðsaðilumÞriðjudaginn 21. apríl 2020 kl. 8:30 verður haldinn afkomufundur fyrir markaðsaðila og fjárfesta. Fundurinn verður eingöngu rafrænn en þar munu Árni Oddur Þórðarson forstjóri og Linda Jónsdóttir fjármálastjóri kynna afkomu félagsins og helstu atriði úr rekstri á fyrsta ársfjórðungi.Fundinum verður vefvarpað beint á www.marel.com/webcast og upptaka verður aðgengileg á www.marel.com/ir eftir fundinn.Markaðsaðilar geta einnig hringt inn á fundinn:IS: +354 800 7520NL: +31 20 721 9496UK: +44 33 3300 9268US: +1 833 823 0586Fjárhagsdagatal2F 2020 – 22. júlí 20203F 2020 – 20. október 20204F 2020 – 3. febrúar 2021FjárfestatengslNánari upplýsingar veita fjárfestatengsl Marel í gegnum netfangið ir@marel.com og í síma...

BERKELEY, Calif. and VANCOUVER, British Columbia, April 14, 2020 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, announces that it has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) outlining certain features thought to expand the clinical applications of BriaCell’s genetically engineered whole-cell immunotherapies to those of infectious diseases including the SARS-CoV-2 virus that causes Coronavirus Disease 2019 (COVID-19).The patent application, entitled “INDUCING IMMUNE RESPONSES BY TRANSFORMING CANCER CELLS INTO ANTIGEN-PRESENTING CELLS”, is based on molecular analyses of the Company’s lead anti-tumor product candidate.Antigen-presenting...

INDEPENDENCE, Ohio, April 14, 2020 (GLOBE NEWSWIRE) — Covia (NYSE:CVIA), a leading provider of mineral-based material solutions for the Industrial and Energy markets, announced a series of actions taken recently to strengthen safety protocols, reduce capacity and lower costs. These actions have been taken in light of the challenges caused by the COVID-19 pandemic and recent dislocations in global oil markets. These actions include:Developed and implemented a series of guidelines and practices to improve safe operating procedures throughout the organization to mitigate the spread of COVID-19.Eliminated non-essential travel and facilitated work from home arrangements.Reduced active Energy capacity by nearly 30% or 6 million tons annually, including the idling of the Utica, Illinois and Kermit, Texas facilities and de-rating capacity...

MEMPHIS, Tenn., April 14, 2020 (GLOBE NEWSWIRE) — First Horizon National Corp. (NYSE:FHN) will announce first quarter financial results in a news release, financial supplement, and slide presentation, prior to the market opening on April 21, 2020. A conference call will follow at 9:00 a.m. CT (U.S.) during which management will review earnings and performance trends. The call will also be available as a live webcast, accompanied by a slide presentation. The news release, call, and slide presentation may involve forward-looking information, including guidance.The slide presentation, financial supplement and news release will be available by 6 a.m. CT that morning at http://ir.fhnc.com/Event.Conference call informationAnalysts, investors and interested parties may call toll-free starting at 8:45 a.m. CT on April 21by dialing 1-888-317-6003...

Nasdaq First North Growth MarketSelskabsmeddelelse nr. 17/2020                                               Odense, 14. april 2020Rettelse til selskabsmeddelelse nr. 16/2020 af den 8. april 2020I selskabsmeddelelse nr. 16/2020 af den 8. april 2020 er der konstateret en fejl i overskriften på meddelelsen.I denne står “Scape Technologies A/S suspenderer forventningerne til 2020 på grund af Covid-19 og udsætter generalforsamling for 2019.” Der skulle retteligt stå (rettelse fremhævet): Scape Technologies A/S suspenderer forventningerne til 2020 på grund af Covid-19 og udsætter generalforsamling for 2020.Yderligere oplysningerCEO Søren Bøving-Andersen, Scape Technologies A/S,mobil: +45 2128 1128, email: sb@scapetechnologies.comScape Technologies A/SØsterbro 5C5000 Odense Cwww.scapetechnologies.comCertified AdviserBaker Tilly...

SEK CREDIT OPERATION ANNOUNCEMENT 2020-04-14All monetary counterparties are invited to submit volume bids to the Riksbank,tel + 46 8 6966970 by 13.30 am on April 14, 2020.Confirmation of bids to e-mail: eol@riksbank.seResult of the auction will be published at 13.45 (CEST)Complete terms and conditions can be retrieved at http://www.riksbank.se